Siemens Healthineers AG (SHL) - Net Assets
Based on the latest financial reports, Siemens Healthineers AG (SHL) has net assets worth €17.72 Billion EUR as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€44.60 Billion) and total liabilities (€26.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €17.72 Billion |
| % of Total Assets | 39.73% |
| Annual Growth Rate | 27.99% |
| 5-Year Change | 45.86% |
| 10-Year Change | N/A |
| Growth Volatility | 55.31 |
Siemens Healthineers AG - Net Assets Trend (2017–2024)
This chart illustrates how Siemens Healthineers AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Siemens Healthineers AG (2017–2024)
The table below shows the annual net assets of Siemens Healthineers AG from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | €18.25 Billion | +0.63% |
| 2023-09-30 | €18.13 Billion | -8.66% |
| 2022-09-30 | €19.85 Billion | +21.50% |
| 2021-09-30 | €16.34 Billion | +30.60% |
| 2020-09-30 | €12.51 Billion | +27.90% |
| 2019-09-30 | €9.78 Billion | +12.75% |
| 2018-09-30 | €8.68 Billion | +167.61% |
| 2017-09-30 | €3.24 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Siemens Healthineers AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 46.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.15 Billion | 11.84% |
| Other Components | €16.05 Billion | 88.16% |
| Total Equity | €18.20 Billion | 100.00% |
Siemens Healthineers AG Competitors by Market Cap
The table below lists competitors of Siemens Healthineers AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orange SA
F:FTE
|
$48.07 Billion |
|
Doosan Heavy Ind. & Const.
KO:034020
|
$48.09 Billion |
|
Cenovus Energy Inc
NYSE:CVE
|
$48.23 Billion |
|
Ford Motor Company
NYSE:F
|
$48.69 Billion |
|
Xcel Energy Inc
NASDAQ:XEL
|
$47.94 Billion |
|
Orange S.A.
PA:ORA
|
$47.88 Billion |
|
Svenska Handelsbanken ser. B
LSE:0R7S
|
$47.38 Billion |
|
Sea Limited
SA:S2EA34
|
$47.29 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Siemens Healthineers AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,081,000,000 to 18,199,000,000, a change of 118,000,000 (0.7%).
- Net income of 1,942,000,000 contributed positively to equity growth.
- Dividend payments of 1,063,000,000 reduced retained earnings.
- Other factors decreased equity by 761,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.94 Billion | +10.67% |
| Dividends Paid | €1.06 Billion | -5.84% |
| Other Changes | €-761.00 Million | -4.18% |
| Total Change | €- | 0.65% |
Book Value vs Market Value Analysis
This analysis compares Siemens Healthineers AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.35x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.80x to 2.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | €3.23 | €38.16 | x |
| 2018-09-30 | €8.66 | €38.16 | x |
| 2019-09-30 | €9.78 | €38.16 | x |
| 2020-09-30 | €11.64 | €38.16 | x |
| 2021-09-30 | €14.54 | €38.16 | x |
| 2022-09-30 | €17.72 | €38.16 | x |
| 2023-09-30 | €16.20 | €38.16 | x |
| 2024-09-30 | €16.27 | €38.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Siemens Healthineers AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.67%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.68%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 2.53x
- Recent ROE (10.67%) is below the historical average (15.74%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 44.12% | 10.34% | 0.67x | 6.32x | €1.10 Billion |
| 2018 | 14.61% | 9.42% | 0.68x | 2.28x | €399.40 Million |
| 2019 | 16.04% | 10.79% | 0.68x | 2.19x | €590.10 Million |
| 2020 | 11.29% | 9.76% | 0.58x | 2.01x | €161.20 Million |
| 2021 | 10.58% | 9.60% | 0.43x | 2.58x | €94.90 Million |
| 2022 | 10.27% | 9.39% | 0.44x | 2.47x | €54.40 Million |
| 2023 | 8.35% | 6.96% | 0.46x | 2.58x | €-299.10 Million |
| 2024 | 10.67% | 8.68% | 0.49x | 2.53x | €122.10 Million |
Industry Comparison
This section compares Siemens Healthineers AG's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $44,770,578,137
- Average return on equity (ROE) among peers: -35.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Siemens Healthineers AG (SHL) | €17.72 Billion | 44.12% | 1.52x | $48.03 Billion |
| Sysmex Corporation (0YX) | $308.67 Billion | 10.72% | 0.38x | $4.84 Billion |
| HeraMED Limited (1I4) | $2.59 Million | -168.10% | 0.60x | $26.40 Million |
| MAUNA KEA TECHNOL.EO -04 (1MK) | $-19.93 Million | 0.00% | 0.00x | $32.08 Million |
| INFUSYSTEMS HLDG.DL-0001 (1TZ) | $57.53 Million | 4.08% | 0.80x | $167.65 Million |
| PHC HOLDINGS CORP. (2GY) | $136.06 Billion | -6.22% | 3.35x | $740.08 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $39.79 Million |
| Guerbet SA (4G8) | $259.10 Million | 10.08% | 0.84x | $137.75 Million |
| Peijia Medical Limited (4WO) | $2.27 Billion | -17.26% | 0.17x | $403.65 Million |
| ENVVENO MEDICAL DL-00001 (5HJ) | $42.16 Million | -51.75% | 0.07x | $196.50K |
| GENTIAN DIAGNOST. NO -01 (6FK) | $194.05 Million | 23.34% | 0.18x | $54.58 Million |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more